Funding Details
- Awarder
- Inbox
- Date Award
- January 19, 2022
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$75,000,000
Company Info
- Founders
- Peter Ghoroghchian
- Company Description
- Revolutionizing gene silencing by developing targeted oligonucleotide therapeutics based on U1 Adaptor technology
- Market
- Oligonucleotide therapeutics
- Location
-
Hillsborough,
NJ,
USA
- Coinvestors
- Affinity Asset Advisors, Boxer Capital, Bristol-Myers Squibb, Janus Henderson Investors, LifeSci Venture Partners, Perceptive Advisors, Qiming Venture Partners, VenBio
Links